Earnings Feed
Start Free
Home/Filings/4/0001567619-22-013787
4//SEC Filing

GHALIE RICHARD G 4

Accession 0001567619-22-013787

CIK 0001262104other
View on SEC.govCompany Profile

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 4:17 PM ET

Size

18.0 KB

Accession

0001567619-22-013787

Insider Transaction Report

Form 4
Period: 2022-07-05
MEI Pharma, Inc.MEIP
GHALIE RICHARD G
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2022-07-05$0.54/sh−8,196$4,426→ 28,927 total
  • Award

    Stock Option (Right to Buy)

    2022-07-05+560,000→ 560,000 total
    Exercise: $0.54Exp: 2032-07-05→ Common Stock (560,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $3.55Exp: 2031-05-03→ Common Stock (75,000 underlying)
    75,000

  • Stock Option (Right to Buy)

    Exercise: $2.52Exp: 2029-07-01→ Common Stock (150,000 underlying)
    150,000

  • Stock Option (Right to Buy)

    Exercise: $1.21Exp: 2026-03-07→ Common Stock (130,000 underlying)
    130,000

  • Stock Option (Right to Buy)

    Exercise: $2.88Exp: 2027-07-07→ Common Stock (65,000 underlying)
    65,000

  • Stock Option (Right to Buy)

    Exercise: $1.38Exp: 2026-07-14→ Common Stock (25,000 underlying)
    25,000

  • Stock Option (Right to Buy)

    Exercise: $4.28Exp: 2028-07-12→ Common Stock (130,000 underlying)
    130,000

  • Stock Option (Right to Buy)

    Exercise: $3.49Exp: 2030-07-02→ Common Stock (150,000 underlying)
    150,000

  • Stock Option (Right to Buy)

    Exercise: $2.95Exp: 2031-07-01→ Common Stock (320,000 underlying)
    320,000
Footnotes (8)
  • [F1]Represents the number of shares withheld by and surrendered to the Issuer on July 5, 2022, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.
  • [F2]One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.
  • [F3]One-quarter of such options vested on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
  • [F4]All options are currently exercisable.
  • [F5]One-quarter of such options vested on July 12, 2019, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
  • [F6]One-quarter of such options vested on July 1, 2020, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
  • [F7]One-quarter of such options vested on July 2, 2021, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
  • [F8]One-quarter of such options vested on May 3, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on May 3, 2022.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

→
Entity typeother

Related Parties

1
  • filerCIK 0001156208

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:17 PM ET
Size
18.0 KB
View on SEC.gov